Thomas Regan, MD
MOHS-Micrographic Surgery · Philadelphia, PANPI 1073585907
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 41 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 22.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $300 and has fallen 63.8% since, to $109 in 2025. That places this record below the midpoint for mohs-micrographic surgery clinicians in PA, where the typical reported total is $1,161.
Across 41 payments — averaging $22.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- LEO Pharma Inc.$204
- Johnson & Johnson$124
- Regeneron Healthcare Solutions, Inc.$91
- Amgen$81
- Prugen, Inc. Pharmaceuticals$67
- Arcutis Biotherapeutics, Inc.$65
- plus $296 from 8 others
What the payments were for
- Food & beverage$927100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| LEO Pharma Inc. | 11 | $204 |
| Johnson & Johnson | 6 | $124 |
| Regeneron Healthcare Solutions, Inc. | 3 | $91 |
| Amgen | 4 | $81 |
| Prugen, Inc. Pharmaceuticals | 1 | $67 |
| Arcutis Biotherapeutics, Inc. | 3 | $65 |
| Lilly USA, LLC | 3 | $57 |
| Incyte Corporation | 2 | $53 |
| AbbVie | 2 | $52 |
| Sun Pharmaceutical Industries Inc. | 2 | $35 |
| Teleflex LLC | 1 | $31 |
| Boehringer Ingelheim | 1 | $28 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Sanofi | 1 | $19 |
How this compares
$927 in reported general payments places this provider in the 40th percentile of 48 mohs-micrographic surgery providers in Pennsylvania.
See all mohs-micrographic surgery providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 28 | $886 |
| Mupirocin | 63 | $395 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Philadelphia
- Jason SchoenfeldPhiladelphia$20K
- Ernest BenedettoPhiladelphia$9K
- Abhishek AphalePhiladelphia$295
- Mark AbdelmalekPhiladelphia$266
- Gregory FulchieroAltoona$24K
- Cynthia BartusAllentown$10K
- Carmen CampanelliYardley$8K
- Aradhna SaxenaFort Washington$8K
- Nicole VelezCranberry Township$6K
- Justin VujevichPittsburgh$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.